Related Experiment Videos
Aspiration curettage for asymptomatic patients receiving estrogen
Obstetrics and Gynecology
|March 1, 1978
Summary
Hormone replacement therapy patients need vigilant monitoring for endometrial cancer. Routine endometrial aspiration curettage effectively detects early lesions and significant pathology before symptoms arise.
Area of Science:
- Gynecology
- Oncology
- Endocrinology
Background:
- Exogenous estrogen use is linked to increased endometrial carcinoma risk.
- Vigorous monitoring is recommended for patients on estrogen therapy.
Purpose of the Study:
- To evaluate endometrial aspiration curettage as a surveillance method for hormone replacement therapy patients.
- To determine the incidence of endometrial pathology in asymptomatic patients on HRT.
Main Methods:
- A prospective study of 208 consecutive patients undergoing hormonal replacement therapy from January 1, 1976, to January 1, 1977.
- Endometrial aspiration curettage was performed for surveillance.
Main Results:
- 16.0% of specimens revealed focal adenomatous hyperplasia or more severe lesions.
- Four cases of endometrial adenocarcinoma and two of atypical adenomatous hyperplasia were identified.
- No patient in the study group experienced abnormal bleeding.
Conclusions:
- Routine endometrial aspiration curettage is effective in diagnosing early endometrial lesions in HRT patients.
- This method can uncover significant endometrial pathology before symptoms manifest.
- The incidence of endometrial pathology in HRT patients may be higher than previously suspected.